Mettler-Toledo International Inc (MTD)
Mettler-Toledo International Inc (MTD) carries a ŷRobot AI score of 74 out of 100. The model's fair value estimate is $1,921.83, 10.5% above the last close of $1,738.91. The chart signal reads Sell.
| Metric | MTD |
|---|---|
| AI score | 74 / 100 |
| Chart signal | Sell |
| Fair value estimate | $1,921.83 |
| Upside to fair value | 10.5% |
| Previous close | $1,738.91 |
| P/E | 37.38 |
| Price / sales | 8.35 |
| Market cap | $34.79B |
| EPS | 46.07 |
| Revenue growth | 1.0% |
| 1-year price change | 4.3% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, Merck & Company Inc, UnitedHealth Group Incorporated, Novartis AG ADR.
Questions about MTD
Is MTD overvalued or undervalued right now?
As of Nov 10, 2026, ŷRobot's fair-value model estimates Mettler-Toledo International Inc (MTD) at $1921.83 against a last close of $1738.91, implying 10.5% upside to the model's estimate.
Is MTD's chart signal bullish or bearish?
The chart-signal model classifies MTD as Neutral as of Nov 13, 2026, with a signal score of -0.11 on a -1 to 1 scale.
What is MTD's ŷRobot AI score?
MTD scores 74 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Nov 13, 2026.
Is MTD stock expensive on P/E and P/S?
MTD trades at 37.4 times earnings and 8.3 times sales as of Nov 13, 2026.
What does MTD's seasonal forecast show?
ŷRobot's seasonal forecast curve for MTD reads +1.6% at 30 days, +4.7% at 90 days, and +4.3% at one year as of Nov 13, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is MTD growing?
Mettler-Toledo International Inc's revenue growth is +1.0% and free-cash-flow growth is +0.2% on the latest reported figures.
MTD chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.